# Oleg Nodelman at EcoR1 Capital > Oleg Nodelman, Founder and Managing Director at EcoR1 Capital. The rounds they were named in and the filings that name them, each with its source. Source: https://millionrounds.com/person/oleg-nodelman (Millionrounds; every figure on the page links to its filing or article) San Francisco, US · Partner # Oleg Nodelman Founder and Managing Director at [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital) Profile summary - **Rounds named:** - none observed - **Filings:** 5 with regulators - **Podcasts:** 1 mentions What this record rests on - **Named in rounds** No round names them yet - ✓ **On filings** 5 filings with a regulator - ✓ **Linked to a firm** At EcoR1 Capital - **Claimed** Not claimed yet Titles come from filings their firm signed. [Correct or remove](https://millionrounds.com/corrections?person=oleg-nodelman)[Is this you? Claim it](https://millionrounds.com/claim?person=oleg-nodelman) ## The firm [**EcoR1 Capital** Private equity · US **0** cheques in 12 months **33** all time **0** led quiet](https://millionrounds.com/fund/ecor1-capital) ## Companies they are listed as backing Portfolio - [Accent Therapeutics](https://millionrounds.com/startup/accent-therapeutics-inc) - [Affinivax](https://millionrounds.com/startup/affinivax) - [Akouos](https://millionrounds.com/company/akouos) - [Aktis Oncology](https://millionrounds.com/startup/aktis-oncology) - [AlloVir](https://millionrounds.com/company/allovir) - [Alpine Immune Sciences](https://millionrounds.com/company/alpine-immune-sciences) - [Arcus Biosciences](https://millionrounds.com/company/arcus-biosciences) - [Artiva Biotherapeutics](https://millionrounds.com/startup/artiva-biotherapeutics) - [Ashvattha Therapeutics](https://millionrounds.com/startup/ashvattha-therapeutics-inc) - [Atara Biotherapeutics](https://millionrounds.com/startup/atara-biotherapeutics) - [Atreca](https://millionrounds.com/company/atreca) - [Avidity Biosciences](https://millionrounds.com/company/avidity-biosciences) - [Cellares](https://millionrounds.com/startup/cellares) - [Centessa Pharmaceuticals](https://millionrounds.com/startup/centessa-pharmaceuticals) - [Chinook Therapeutics](https://millionrounds.com/startup/chinook-therapeutics) - [Clementia Pharmaceuticals](https://millionrounds.com/startup/clementia-pharmaceuticals) - [Codiak Biosciences](https://millionrounds.com/startup/codiak-biosciences) - [Dewpoint Therapeutics](https://millionrounds.com/company/dewpoint-therapeutics) - [Editas Medicine](https://millionrounds.com/startup/editas-medicine) - [ElevateBio](https://millionrounds.com/company/elevatebio) - [Freenome](https://millionrounds.com/company/freenome) - [Intellia Therapeutics](https://millionrounds.com/startup/intellia-therapeutics) - [Kezar Life Sciences](https://millionrounds.com/company/kezar-life-sciences) - [Kronos Bio](https://millionrounds.com/company/kronos-bio) - [Kura Oncology](https://millionrounds.com/startup/kura-oncology) - [Magenta Therapeutics](https://millionrounds.com/company/magenta-therapeutics) - [Metacrine](https://millionrounds.com/company/metacrine) - [Morphic Therapeutic](https://millionrounds.com/company/morphic-therapeutic) - [Neogene Therapeutics](https://millionrounds.com/startup/neogene-therapeutics) - [Neurogene](https://millionrounds.com/company/neurogene) - [Notch Therapeutics](https://millionrounds.com/startup/notch-therapeutics) - [Nurix Therapeutics](https://millionrounds.com/startup/nurix-therapeutics) - [Nuvation Bio](https://millionrounds.com/company/nuvation-bio) - [ORIC Pharmaceuticals](https://millionrounds.com/company/oric-pharmaceuticals) - [Peloton Therapeutics](https://millionrounds.com/company/peloton-therapeutics) - [Prevail Therapeutics](https://millionrounds.com/company/prevail-therapeutics) 36 of 57 companies. ## Where they are named on record Filings - SEC Form D · Venture Capital fund **[EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital)** Manager of Biotech Opportunity GP, LLC, General Partner on 4 filings · since 2019 - SEC Form D · Hedge fund **EcoR1 Special Opportunity Fund III, L.P.** Manager of EcoR1 Capital, LLC, General Partner on 3 filings · since 2017 - SEC Form D · Hedge fund **EcoR1 Special Opportunity Fund II, L.P.** Manager of EcoR1 Capital, LLC, General Partner since 2015 - SEC Form D · Hedge fund **EcoR1 Special Opportunity Fund I, L.P.** Manager of EcoR1 Capital, LLC, General Partner since 2015 - SEC Form D · Hedge fund **[EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital)** Manager of EcoR1 Capital, LLC, General Partner on 28 filings · since 2013 Each row is a document a firm filed with a regulator: somebody signed it, and it carries a date. ## Also at EcoR1 Capital - [**Caroline Stout** Partner *0 rounds*](https://millionrounds.com/person/caroline-stout) - [**Daniel Rodriguez** CEO / Founder *0 rounds*](https://millionrounds.com/person/daniel-rodriguez) - [**Sarah Marriott** Chief Operating Officer *0 rounds*](https://millionrounds.com/person/sarah-marriott) - [**Scott Platshon** Acting Chief Investment Officer *0 rounds*](https://millionrounds.com/person/scott-platshon) ## Hear them before you pitch them ### Mentioned in Episodes that name Oleg Nodelman in their description, which is not the same as being on them. - [All-In](https://millionrounds.com/podcasts/all-in) · 12 Jun 2026 · 1h 8m All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live Mentions [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital)[Multicoin Capital](https://millionrounds.com/fund/multicoin-capital)[Kyle Samani](https://millionrounds.com/person/kyle-samani)[Oleg Nodelman](https://millionrounds.com/person/oleg-nodelman) About this episode (0:00) Chamath explains the Best Ideas format (2:31) Suvretta Capital Management's Aaron Cowen pitches MGM Resorts (13:07) Bornite Capital's Dan Dreyfus pitches Talen Energy (27:19) EcoR1 Capital's Oleg Nodelman pitches Aktis Oncology (40:20) Multicoin Capital's Kyle Samani pitches GEODNET… More on the show's page Listen on Apple PodcastsThe show's page Episodes of [the shows we follow](https://millionrounds.com/podcasts), matched by name. Not them? [Tell us](https://millionrounds.com/corrections?person=oleg-nodelman). ## Find people like Oleg Filter every partner and angel by firm, kind, market and whether we watched them invest. Free with an account. Search people[How we know what we know](https://millionrounds.com/methodology)